New studies reveal Curcuma kwangsiensis radix’s antiplatelet properties via three novel sesquiterpenoids, with AI models predicting thrombin inhibition and WHO endorsing standardized research. B...
New 2024 data reveals boswellia’s efficacy against aromatase inhibitor-induced arthritis, while rhodiola outperforms eleuthero for fatigue. Emerging interaction risks demand precision in herbal ...
July 2023 research reveals Guangxi-sourced CKR contains 18% more curdione than Yunnan varieties, with molecular docking demonstrating thrombin inhibition at IC50 32μM, aligning with new WHO herbal st...
Recent studies reveal how AI-powered analysis of Curcumae kwangsiensis radix addresses quality standardization challenges, while EMA and WHO actions signal growing Western acceptance of evidence-based...
Chinese researchers discover key bioactive compounds and serum metabolites in Curcumae Kwangsiensis through advanced HPLC and molecular docking techniques, potentially revolutionizing TCM quality cont...
Emerging research highlights the efficacy of hibiscus, dandelion, and celery as natural diuretics for blood pressure management, while new FDA advisories caution against unregulated combinations with ...
New research reveals how climate variability affects CKR’s phytochemical profile, prompting calls for adaptive quality markers in China’s TCM standardization efforts. Recent studies show r...
Recent studies demonstrate Curcumae kwangsiensis radix’s superior anti-thrombotic properties, with Guangxi-origin samples showing exceptional activity through advanced quality marker identificat...
Recent studies highlight regional variations in Curcuma kwangsiensis radix’s anti-thrombotic properties, with blockchain technology emerging as a solution for quality control and supply chain in...
New herbal cubosome technology enhances arthritis treatment by improving bioavailability and targeting inflammation with fewer side effects than conventional drugs. Cutting-edge herbal cubosomes offer...
